SANDRA SMITH-KIRBY: Open Payments
NPI 1740785799 · WINTERVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 14 payments from 10 companies in 2025. Trend: 2023 $997 · 2024 $547 · 2025 $590
Food & beverage: $570Education: $20
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $109 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Fresenius USA Marketing, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Mannkind Corporation | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: TARPEYO, Kerendia, GVOKE HYPOPEN, VELPHORO, AFREZZA, Ozempic, RAYALDEE, VOYXACT.
Industry payments across NC — which companies pay providers there.
